REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / COMMON STOCK
Shares outstanding
104,986,330
Total 13F shares
1,458,057
Share change
+796,118
Total reported value
$456,100,415
Price per share
$312.87
Number of holders
19
Value change
+$249,187,180
Number of buys
10
Number of sells
5

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2013

As of 30 Sep 2013 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,458,057 shares of stock of the company.
Largest 10 holders included WELLS FARGO & COMPANY/MN, Citadel Advisors LLC, Partner Fund Management, L.P., Retirement Systems of Alabama, Zurcher Kantonalbank (Zurich Cantonalbank), HARTFORD INVESTMENT MANAGEMENT CO, Partner Investment Management, L.P., PDT Partners, LLC, State of Tennessee, Treasury Department, and DIAM Co., Ltd..
This table shows 19 institutional shareholders of the security as of 30 Sep 2013.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.